Investment Firms Boost Offer For Italian Pharma Biz Recordati
Investment companies CVC and Groupe Bruxelles Lambert upped their offer on Tuesday for Italian pharmaceutical company Recordati from €51.29 ($58) to €53.71 per share, representing the "best and final offer" as the...To view the full article, register now.
Already a subscriber? Click here to view full article